Y
Yugo Shibagaki
Researcher at St. Marianna University School of Medicine
Publications - 294
Citations - 3445
Yugo Shibagaki is an academic researcher from St. Marianna University School of Medicine. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 23, co-authored 257 publications receiving 2357 citations.
Papers
More filters
Journal ArticleDOI
Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder
Masafumi Fukagawa,Keitaro Yokoyama,Fumihiko Koiwa,Masatomo Taniguchi,Tetsuo Shoji,Junichiro James Kazama,Hirotaka Komaba,Ryoichi Ando,Takatoshi Kakuta,Hideki Fujii,Msasaaki Nakayama,Yugo Shibagaki,Seiji Fukumoto,Naohiko Fujii,Motoshi Hattori,Akira Ashida,Kunitoshi Iseki,Takashi Shigematsu,Yusuke Tsukamoto,Yoshiharu Tsubakihara,Tadashi Tomo,Hideki Hirakata,Tadao Akizawa +22 more
TL;DR: CKD-MBD Guideline Working Group, Japanese Society for Dialysis Therapy, and Tadao Akizawa thank the authors for their help and assistance in the development of this guideline.
Journal ArticleDOI
Adrenomedullin, an Endogenous Peptide, Counteracts Cardiovascular Damage
Tatsuo Shimosawa,Yugo Shibagaki,Kotaro Ishibashi,Kazuo Kitamura,Kenji Kangawa,Shigeaki Kato,Katsuyuki Ando,Toshiro Fujita +7 more
TL;DR: The evidence presented supports the hypothesis that endogenous AM possesses a protective action against cardiovascular damage, possibly through the inhibition of oxidative stress production.
Journal ArticleDOI
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kenjiro Kimura,Tatsuo Hosoya,Shunya Uchida,Masaaki Inaba,Hirofumi Makino,Shoichi Maruyama,Sadayoshi Ito,Tetsuya Yamamoto,Yasuhiko Tomino,Iwao Ohno,Yugo Shibagaki,Satoshi Iimuro,Naohiko Imai,Masanari Kuwabara,Hiroshi Hayakawa,Hiroshi Ohtsu,Yasuo Ohashi,Seiichi Matsuo,Hisashi Yamanaka,Tadao Akizawa,Tamio Teramoto,Hiroshi Kasanuki,Kenichi Yoshimura,Hiroshi Sato,Satoshi Horikoshi,Syoichi Maruyama,Masahiko Inaba,Yuji Moriwaki,Haruhito Uchida,Nagayuki Kaneshiro,Hidekazu Moriya,Yasuhiro Komatsu,Shinya Kaname,Kazunari Hanaoka,Makoto Ogura,Masato Ikeda,Kenji Kasai,Akira Sugiura,Kazushi Takahashi,Kenichiro Kojima,Kosaku Nitta,Hirofumi Tamai,Hiroshi Nagaya,Senji Okuno,Ryusuke Kakiya,Hiroya Takeoka,Kyouji Hirata,Kenichiro Asano,Yasuo Fukaya,Yasushi Iwaida,Yasuo Tsuneda,Shigeaki Nishimura,Takeyuki Hiramatsu,Yoshitaka Isaka,Takafumi Ito,Yukio Yuzawa,Kunihiro Yamagata,Tadashi Sofue,Yoshimi Jinguji,Keita Hirano,Kazuhiro Matsuyama,Teruhiko Mizumoto,Yuko Shibuya,Masahiro Sugawara,Moritoshi Kadomura,Yasuaki Teshima,Hiroshi Ohtani,Hiroki Kamata,Susumu Okawara,Masaki Fukushima,Katsumi Takemura,Eriko Kinugasa,Masami Kogure,Yoichi Ehara +73 more
TL;DR: Compared to placebo, febuxostat did not mitigate the decline in kidney function among patients with stage 3 CKD and asymptomatic hyperuricemia andSubgroup analysis demonstrated a significant benefit from febUXostat in patients without proteinuria and for whom serum creatinine concentration was lower than the median.
Journal ArticleDOI
Development of Risk Prediction Equations for Incident Chronic Kidney Disease
Robert G. Nelson,Morgan E. Grams,Shoshana H. Ballew,Yingying Sang,Fereidoun Azizi,Steven J. Chadban,Layal Chaker,Stephan C. Dunning,Caroline S. Fox,Yoshihisa Hirakawa,Kunitoshi Iseki,Joachim H. Ix,Joachim H. Ix,Tazeen H. Jafar,Tazeen H. Jafar,Tazeen H. Jafar,Anna Köttgen,Anna Köttgen,David M.J. Naimark,Takayoshi Ohkubo,Gordon Prescott,Casey M. Rebholz,Charumathi Sabanayagam,Toshimi Sairenchi,Ben Schöttker,Ben Schöttker,Yugo Shibagaki,Marcello Tonelli,Luxia Zhang,Ron T. Gansevoort,Kunihiro Matsushita,Mark Woodward,Mark Woodward,Mark Woodward,Josef Coresh,Varda Shalev +35 more
TL;DR: Assessment tools to identify individuals at increased risk of CKD, defined by reduced estimated glomerular filtration rate (eGFR), developed from more than 5 million individuals from 34 multinational cohorts demonstrated high discrimination and variable calibration in diverse populations.
Journal ArticleDOI
Decreased physical function in pre-dialysis patients with chronic kidney disease.
Koji Hiraki,Takashi Yasuda,Chiharu Hotta,Kazuhiro P. Izawa,Yuji Morio,Satoshi Watanabe,Tsutomu Sakurada,Yugo Shibagaki,Kenjiro Kimura +8 more
TL;DR: Physical function in pre-dialysis CKD patients decreased as the disease progressed according to stage, and age, female sex, body mass index, eGFR and urinary protein were significantly correlated with indices of physical function.